Displaying 1 - 12 of 29

Display:

12 24 48

Liver Tumours

4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View

Liver Tumours

4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View

Liver Tumours

4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View

Liver Tumours

4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View

Immune-Mediated and Cholestatic Diseases

4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View

Liver Tumours

5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View

Liver Tumours

5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View

Displaying 1 - 12 of 29

Display:

12 24 48